ADVERTISEMENT
  • The Membership Club
  • PT Hausa
  • About Us
  • Advert Rates
  • Careers
  • Contact Us
Thursday, January 21, 2021
Premium Times Nigeria
  • Home
  • COVID-19
  • News
    • Headline Stories
    • Top News
    • More News
    • Foreign
  • Investigations
  • Business
    • News Reports
    • Financial Inclusion
    • Analysis and Data
    • Business Specials
    • Opinion
    • Oil/Gas Reports
      • FAAC Reports
      • Revenue
  • Opinion
  • Health
    • News Reports
    • Investigations
    • Data and Infographics
    • Health Specials
    • Features
    • Events
    • Primary Health Tracker
  • Agriculture
    • News Report
    • Research & Innovation
    • Data & Infographics
    • Special Reports/Features
    • Investigations
    • Interviews
    • Markets
  • Arts/Life
    • Arts/Books
    • Kannywood
    • Lifestyle
    • Music
    • Nollywood
    • Travel
  • Sports
    • Football
    • More Sports News
    • Sports Features
  • Projects
    • Parliament Watch
    • Panama Papers
    • Paradise Papers
    • AGAHRIN
  • Home
  • COVID-19
  • News
    • Headline Stories
    • Top News
    • More News
    • Foreign
  • Investigations
  • Business
    • News Reports
    • Financial Inclusion
    • Analysis and Data
    • Business Specials
    • Opinion
    • Oil/Gas Reports
      • FAAC Reports
      • Revenue
  • Opinion
  • Health
    • News Reports
    • Investigations
    • Data and Infographics
    • Health Specials
    • Features
    • Events
    • Primary Health Tracker
  • Agriculture
    • News Report
    • Research & Innovation
    • Data & Infographics
    • Special Reports/Features
    • Investigations
    • Interviews
    • Markets
  • Arts/Life
    • Arts/Books
    • Kannywood
    • Lifestyle
    • Music
    • Nollywood
    • Travel
  • Sports
    • Football
    • More Sports News
    • Sports Features
  • Projects
    • Parliament Watch
    • Panama Papers
    • Paradise Papers
    • AGAHRIN
Premium Times Nigeria
BUA Group Ad BUA Group Ad BUA Group Ad
ADVERTISEMENT
Covid-19 Laboratory test [PHOTO CREDIT: The Scientist Magazine]

Covid-19 Laboratory test [PHOTO CREDIT: The Scientist Magazine]

Argentina approves AstraZeneca-Oxford COVID-19 vaccine

Argentina is the second country to approve the COVID-19 vaccine.

byAgency Report
December 31, 2020
1 min read
ADVERTISEMENT

Argentina has approved the coronavirus vaccine developed by the Oxford University and the pharmaceutical company AstraZeneca, making it the second country after Britain to do so.

The country’s drug regulator Anmat said it granted an emergency registration limited to one year for the sale of the vaccine.

The regulator said the risk-benefit ratio of the product was acceptable.

Britain had also granted emergency approval to the vaccine made by the British-Swedish pharmaceutical company AstraZeneca and Oxford University.

The drug had shown lower efficacy in trials than BioNtech/Pfizer vaccine already approved in some countries, including Argentina.

However, it can be stored with far less effort and is much cheaper.

On Tuesday, Argentina had started to administer the Russia-developed Sputnik V vaccine.

According to official figures, Argentina, which has a population of around 45 million, has recorded around 1.6 million coronavirus infections and 43,000 deaths.

Later, El Salvador’s Central American drug authority, DNM, said it had granted emergency approval for importation, distribution and use of the vaccine.

RelatedNews

India to send coronavirus vaccines to 6 neighbouring countries

Britain records ‘highest coronavirus death rate’ worldwide- Report

WHO urges countries to shun vaccine nationalism

UK approves Oxford-AstraZeneca COVID-19 vaccine

For both Latin American countries, it was initially unclear when the drug was expected to be used and how many doses each would receive.

Mexico’s Foreign Minister Marcelo Ebrard stated that approval was imminent in the country.

In August, the governments of Argentina and Mexico had agreed with AstraZeneca that the vaccine would be manufactured for all of Latin America except Brazil if approved in the two countries. (dpa/NAN)

Dangote adbanner 728x90_2 (1)

  • WhatsApp
  • Tweet
  • Email
  • Print
  • Telegram
  • More
  • Share on Tumblr
  • Pocket

Support PREMIUM TIMES' journalism of integrity and credibility

Good journalism costs a lot of money. Yet only good journalism can ensure the possibility of a good society, an accountable democracy, and a transparent government.

For continued free access to the best investigative journalism in the country we ask you to consider making a modest support to this noble endeavour.

By contributing to PREMIUM TIMES, you are helping to sustain a journalism of relevance and ensuring it remains free and available to all.

Donate


TEXT AD: To advertise here . Call Willie +2347088095401...


JOIN THE CONVERSATION

  • Disqus (0)
premiumtimes



PT Mag Campaign AD

Previous Post

Yahaya Bello signs N130bn 2021 budget

Next Post

2020: 20 great PREMIUM TIMES stories you need to read again

Agency Report

Agency Report

More News

Sample coronavirus test [PHOTO: Euronews] hospital COVID-19

17% of Nigerians don’t believe COVID-19 is real – Report

January 20, 2021
COVID-19 vaccine vials [PHOTO CREDIT: BioWorld]

COVID-19: AU vaccine plan proposes up to $10 per dose for Nigeria, others

January 20, 2021
World Health Organisation (WHO) Director-General, Tedros Ghebreyesus at the coronavirus press conference in Geneva

WHO reports large shortage of coronavirus vaccines

January 20, 2021
Lagos State governor, Babajide Sanwo-Olu

Lagos to treat malaria-like symptoms as COVID-19 – Governor

January 19, 2021
Lagos State Governor, Mr. Babajide Sanwo-Olu

COVID-19: Lagos govt begins talks with vaccine manufacturers – Sanwo-Olu

January 19, 2021
Minister of Health, Osagie Ehanire

COVID-19: Nigeria releases N10 bn for vaccine production

January 18, 2021
Next Post
EndSARS Protesters in Abuja 2020

2020: 20 great PREMIUM TIMES stories you need to read again

COVID-19: Coronavirus Test Sample

Five COVID-19 strains circulating in Ukraine – official

Discussion about this post

Search

#EndSARS: Latest Updates




Polaris Bank


JAIZ Ad


NITDA Ad




Advertisement






netherland biz school Advert

Zenith Advert

Heritage Advert
ADVERTISEMENT

Our Digital Network

  • PT Hausa
  • Election Centre
  • Human Trafficking Investigation
  • Centre for Investigative Journalism
  • National Conference
  • Press Attack Tracker
  • PT Academy
  • Dubawa
  • LeaksNG
  • Campus Reporter

Resources

  • Oil & Gas Facts
  • List of Universities in Nigeria
  • LIST: Federal Unity Colleges in Nigeria
  • NYSC Orientation Camps Address Nationwide
  • Nigeria’s Federal/States’ Budgets since 2005
  • Malabu Scandal Thread
  • World Cup 2018
  • Panama Papers Game
  • Our Digital Network
  • About Us
  • Resources
  • Projects
  • Data & Infographics
  • DONATE

All content is Copyrighted © 2020 The Premium Times, Nigeria

No Result
View All Result
  • Home
  • COVID-19
  • News
    • Headline Stories
    • Top News
    • More News
    • Foreign
  • Investigations
  • Business
    • News Reports
    • Financial Inclusion
    • Analysis and Data
    • Business Specials
    • Opinion
    • Oil/Gas Reports
      • FAAC Reports
      • Revenue
  • Health
    • News Reports
    • Investigations
    • Data and Infographics
    • Health Specials
    • Features
    • Events
    • Primary Health Tracker
  • Agriculture
    • News Report
    • Research & Innovation
    • Data & Infographics
    • Special Reports/Features
    • Investigations
    • Interviews
    • Markets
  • Arts/Life
    • Arts/Books
    • Kannywood
    • Lifestyle
    • Music
    • Nollywood
    • Travel
  • Sports
    • Football
    • More Sports News
    • Sports Features
  • Projects
    • Panama Papers
    • Paradise Papers
    • Parliament Watch
    • AGAHRIN
  • Opinion
  • PT Hausa
  • The Membership Club
  • Dubawa
    • Dubawa NG
  • About Us
  • Advert Rates
  • Careers
  • Contact Us
  • Digital Store
  • DONATE

All content is Copyrighted © 2020 The Premium Times, Nigeria

Our website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.